ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C09DA09 | B | Azilsartan medoxomil - 40mg, Chlortalidone - 25mg | 9804 | 17919/1 | EDARBYCLOR | 28 | Tablet | Oral | Century Pharma SAL | Takeda Ireland Ltd | Ireland | 1,846,440 L.L | 23.08 | B | Takeda Pharma AS | Denmark | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C09DA09 | B | Azilsartan medoxomil - 40mg, Chlortalidone - 25mg | 7844 | 35014/1 | EDARBYCLOR | 28 | Tablet | Oral | Century Pharma SAL | Takeda Pharmaceutical Company Ltd, Osaka | Japan | 1,846,440 L.L | 23.08 | B | Takeda Pharmaceuticals USA Inc | USA | 2/5/2024 | 0 | |
C09DA09 | B | Azilsartan medoxomil - 40mg, Chlortalidone - 25mg | 11700 | 36022/1 | EDARBYCLOR | 28 | Tablet, film coated | Oral | Century Pharma SAL | The Arab Pharmaceutical Manufacturing PSC, Sult under license from Takeda Pharmaceuticals International AG, Switzerland | Jordan | 1,846,440 L.L | 23.08 | B | The Arab Pharmaceutical Manufacturing PSC, Sult | Jordan | 2/5/2024 | 0 |